LCD L36186: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease — Noridian
Policy LCD-L36186 · Hematology
Impact on genetic testing billing for myeloproliferative diseases.
Code intelligence
C94.00 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C94.00.
Elevated code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Elevated
0
Critical
0%
1
High
33%
2
Routine
67%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L38125: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies — Noridian
Policy LCD-L38125 · Oncology
New LCD for myeloid malignancies requires billing team review.
LCD L38123: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies — Noridian
Policy LCD-L38123 · Oncology
New LCD impacts myeloid malignancies testing billing.
Audit documentation
Building an audit file that includes C94.00?
The Tripwire Audit Pack exports 12 months of Hematology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Hematology audit pack — $349One-time purchase · not a subscription